MRNA — Moderna Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Annual balance sheet for Moderna, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	1,103	4,608	10,727	9,902	8,604
Net Total Accounts Receivable
Net Total Receivables	16.3	1,411	3,296	1,664	1,081
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	1,129	6,298	16,071	13,431	10,325
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	288	387	1,383	2,139	2,658
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	1,589	7,337	24,669	25,858	18,426
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	143	4,389	9,128	4,923	3,015
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	415	4,775	10,524	6,735	4,572
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	1,175	2,561	14,145	19,123	13,854
Total Liabilities & Shareholders' Equity	1,589	7,337	24,669	25,858	18,426
Total Common Shares Outstanding